Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

NCT03678753 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Generalized Epilepsy

Interventions

DRUG: Cenobamate
DRUG: Placebo

Sponsor

SK Life Science, Inc.